Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $15.79 in the last session, up 0.77% from day before closing price of $15.67. In other words, the price has increased by $0.77 from its previous closing price. On the day, 0.73 million shares were traded. CNTA stock price reached its highest trading level at $16.5551 during the session, while it also had its lowest trading level at $15.71.
Ratios:
We take a closer look at CNTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 13.29 and its Current Ratio is at 13.29. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 20, 2024, Upgraded its rating to Overweight and sets its target price to $26 from $11 previously.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.
On July 18, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on July 18, 2024, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 25 ’24 when Weinhoff Gregory M sold 16,619 shares for $15.69 per share. The transaction valued at 260,724 led to the insider holds 206,750 shares of the business.
Weinhoff Gregory M bought 16,619 shares of CNTA for $262,580 on Sep 25 ’24. On Sep 20 ’24, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $16.53 each. As a result, the insider received 908,985 and left with 721,924 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2030104448 and an Enterprise Value of 1580047744. For the stock, the TTM Price-to-Sale (P/S) ratio is 258.63 while its Price-to-Book (P/B) ratio in mrq is 6.23. Its current Enterprise Value per Revenue stands at 230.563 whereas that against EBITDA is -10.187.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $17.59, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is 23.32%, while the 200-Day Moving Average is calculated to be 55.54%.
Shares Statistics:
According to the various share statistics, CNTA traded on average about 558.99K shares per day over the past 3-months and 694570 shares per day over the past 10 days. A total of 98.77M shares are outstanding, with a floating share count of 75.51M. Insiders hold about 33.28% of the company’s shares, while institutions hold 43.30% stake in the company. Shares short for CNTA as of 1726185600 were 1502616 with a Short Ratio of 2.69, compared to 1723680000 on 1100048. Therefore, it implies a Short% of Shares Outstanding of 1502616 and a Short% of Float of 1.6900001000000002.
